OPY vs PODD · P/E 13, rev $1.43B vs P/E 34, rev $2.07B
Oppenheimer Holdings Inc (OPY) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
OPY currently screens at market cap $1.15B and trailing P/E 12.8. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the OPY and PODD stock pages for the full models.
Not investment advice.